Essential pre-pregnancy and pregnancy interventions for improved maternal, newborn and child health

Reproductive Health

Volumn 11, Issue , 2014, Pages

  Lassi, Zohra S ^a   Mansoor, Tarab ^a   Salam, Rehana A ^a   Das, Jai K ^a   Bhutta, Zulfiqar A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

essential interventions; preconception; pregnancy; prepregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTIRETROVIRUS AGENT; CALCIUM; CORTICOSTEROID; FOLIC ACID; IRON;

ANEMIA; BED NET; BREECH PRESENTATION; CHILD HEALTH; COGNITIVE THERAPY; DISEASE SEVERITY; ECLAMPSIA; FAMILY PLANNING; GESTATIONAL AGE; HEALTH CARE PRACTICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LOW DRUG DOSE; MALARIA; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNAL WELFARE; NEURAL TUBE DEFECT; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN TETANUS; PATIENT CARE; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL CARE; PREPREGNANCY CARE; PROFESSIONAL PRACTICE; REVIEW; SEXUALLY TRANSMITTED DISEASE; SMOKING CESSATION; SYPHILIS; TETANUS PROPHYLAXIS; UNPLANNED PREGNANCY; VERTICAL TRANSMISSION; VITAMIN SUPPLEMENTATION; DIET SUPPLEMENTATION; FEMALE; INFANT; INFANT MORTALITY; MATERNAL CARE; NEWBORN; POVERTY; PREGNANCY; PREGNANCY COMPLICATIONS; PREVENTION AND CONTROL; PROCEDURES; SEXUALLY TRANSMITTED DISEASES;

DIETARY SUPPLEMENTS; FAMILY PLANNING SERVICES; FEMALE; FOLIC ACID; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; IRON; MATERNAL DEATH; POVERTY; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; SEXUALLY TRANSMITTED DISEASES;

EID: 84906925866     PISSN: None     EISSN: 17424755     Source Type: Journal    
DOI: 10.1186/1742-4755-11-S1-S2     Document Type: Review

References (120)

1. Interventions to prevent hypothermia at birth in preterm and/or low birthweight infants. McCall EM, Alderdice F, Halliday HL, Jenkins JG, Vohra S, Cochrane Database Syst Rev 2010 3 3 D004210 20238329
2. WHO recommendations for the prevention and treatment of postpartum haemorrhage. WHO, Geneva, Switzerland: World Health Organisation 2012
3. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, Dwyer-Lindgren L, Lofgren KT, Phillips D, Atkinson C, Lancet 2011 378 9797 1139 1165 10.1016/S0140-6736(11)61337-8 21937100
4. Implementing community-based perinatal care: results from a pilot study in rural Pakistan. Bhutta ZA, Memon ZA, Soofi S, Salat MS, Cousens S, J M, Bulletin of the World Health Organization 2008 86 452 459 18568274
5. Effect of participatory intervention with women's groups on birth outcomes in Nepal: cluster randomised control trial. Manandhar DS, Osrin D, Shrestha BP, Mesko N, Morrison J, Tumbahangphe, KM TS, Thapa S, Shrestha D, Thapa B, et al. Lancet 2004 364 970 979 10.1016/S0140-6736(04)17021-9 15364188
6. Effect of scaling up women's groups on birth outcomes in three rural districts in Bangladesh: a cluster-randomised controlled trial. Azad K, Barnett S, Banerjee B, Shaha S, Khan K, Rega AR, Barua S, Flatman D, Pagel C, Prost A, et al. Lancet 2010 375
7. Effect of participatory intervention with women's groups on birth outcomes and maternal depression in Jharkhand and Orissa, India: a cluster-randomised controlled trial. [In press]. Tripathy P, Nair N, Barnett S, Mahapatra R, Borghi J, Rath S, Gope R, Mahto D, Sinha R, Lakshminarayana R, et al. Lancet 2010 375
8. Women's groups' perceptions of maternal health issues in rural Malawi. Rosato M, Mwansambo CW, Kazembe PN, Phiri T, Soko QS, Lewycka S, Kunyenge BE, Vergnano S, Osrin D, Newell ML, The Lancet 2006 368 9542 1180 1188 10.1016/S0140-6736(06)69475-0
9. Implementing a community-based participatory intervention to improve essential newborn care in rural Nepal. Osrin D, Mesko N, Shrestha BP, Shrestha D, Tamang S, Thapa S, Tumbahangphe KM, Shrestha JR, Manandhar MK, Manandhar DS, TRANSACTIONS-ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2003 97 1 18 21 10.1016/S0035-9203(03)90008-3
10. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial. Baqui AH, El-Arifeen S, Darmstadt GL, Ahmed S, Williams EK, Seraji HR, Mannan I, Rahman SM, Shah R, Saha SK, The Lancet 2008 371 9628 1936 1944 10.1016/S0140-6736(08)60835-1
11. Effect of community-based behaviour change management on neonatal mortality in Shivgarh, Uttar Pradesh, India: a cluster-randomised controlled trial. Kumar V, Mohanty S, Kumar A, Misra RP, Santosham M, Awasthi S, Baqui AH, Singh P, Singh V, Ahuja RC, The Lancet 2008 372 9644 1151 1162 10.1016/S0140-6736(08)61483-X
12. Behaviour change in perinatal care practices among rural women exposed to a women's group intervention in Nepal. Wade A, Osrin D, Shrestha BP, Sen A, Morrison J, Tumbahangphe KM, BMC Pregnancy and Childbirth 2006 6 20 10.1186/1471-2393-6-20 16776818
13. Essential interventions for maternal, newborn and child health: background and methodology. Lassi ZS, Salam RA, Dai JK, Bhutta ZA, Reproductive Health 2014 11 Suppl 1 1
14. Unsafe abortion Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. World Health Organization, EDITION S 2011 http://whqlibdoc.who.int/publications/2011/9789241501118-eng.pdf
15. The risk of maternal nutritional depletion and poor outcomes increases in early or closely spaced pregnancies. King JC, J Nutr 2003 133 5 1732S 1736S 12730491
16. Effect of the interval between pregnancies on the health of mother and child. Rousso D, Panidis D, Gkoutzioulis F, Kourtis A, Mavromatidis G, Kalahanis I, Eur J Obstet Gynecol Reprod Biol 2002 105 1 4 6 10.1016/S0301-2115(02)00077-5 12270555
17. The effects of birth spacing on child and maternal health. Winikoff B, Stud Fam Plann 1983 14 10 231 245 10.2307/1965748 6648993
18. Effect of the interpregnancy interval after an abortion on maternal and perinatal health in Latin America. Conde-Agudelo A, Belizan JM, Breman R, Brockman SC, Rosas-Bermudez A, Int J Gynecol Obstet 2005 89 34 S40
19. Birth spacing and risk of adverse perinatal outcomes. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC, JAMA 2006 295 15 1809 1823 10.1001/jama.295.15.1809 16622143
20. Effects of birth spacing on maternal health: a systematic review. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC, Am Obstet Gynecol 2007 196 4 297 308 10.1016/j.ajog.2006.05.055
21. The associations of birth intervals with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. Kozuki N, Lee ACC, Silveira MF, Victora CG, Adair L, Humphrey J, Ntozini R, Black RE, Katz J, BMC Public Health 2013 13 Suppl 3 3
22. Understanding risk: a randomized controlled trial of communicating contraceptive effectiveness. Steiner MJ, Dalebout S, Condon S, Dominik R, Trussell J, Obstet Gynecol 2003 102 4 709 717 10.1016/S0029-7844(03)00662-8 14551000
23. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Anglemyer A, Rutherford GW, Horvath T, Baggaley RC, Egger M, Siegfried N, Cochrane Database Syst Rev 2013 4 4 D009153 23633367
24. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Ng B, Butler L, Horvath T, Rutherford G, Cochrane Database Syst Rev 2011 3 3 D00122
25. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Czeizel AE, BMJ 1993 306 6893 1645 10.1136/bmj.306.6893.1645 8324432
26. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991 338 760 131 137 1677062
27. Folic acid: influence on the outcome of pregnancy. Scholl TO, Johnson WG, Am J Clin Nutr 2000 71 5 1295s 1303s 10799405
28. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects; MMWR 1992; 41(No. RR-14). CDC centers for disease control, 1992
29. Folic acid to reduce neonatal mortality from neural tube disorders. Blencowe H, Cousens S, Modell B, Lawn J, Int J Epidemiol 2010 39 Supplement 1 110 10.1093/ije/dyq028 20348114
30. Effects and safety of periconceptional folate supplementation for preventing birth defects. De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP, Cochrane Database Syst Rev 2010 10 Issue D007950 20927767
31. The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths. Imdad A, Yakoob MY, Bhutta ZA, BMC Public Health 2011 11 Suppl 3 4 10.1186/1471-2458-11-S3-S4
32. Patterns of routine antenatal care for low-risk pregnancy. Villar J, Carroli G, Khan-Neelofur D, Piaggio G, Gulmezoglu M, Cochrane Database Syst Rev 2001 4 4 D000934 11687086
33. WHO systematic review of randomised controlled trials of routine antenatal care. Carroli G, Villar J, Piaggio G, Khan-Neelofur D, Gulmezoglu M, Mugford M, Lumbiganon P, Farnot U, Bersgo P, Lancet 2001 357 9268 1565 1570 10.1016/S0140-6736(00)04723-1 11377643
34. Alternative versus standard packages of antenatal care for low-risk pregnancy. Dowswell T, Carroli G, Duley L, Gates S, Gulmezoglu AM, Khan-Neelofur D, Piaggio GGP, Cochrane Database Syst Rev 2010 10 10 D000934 20927721
35. Group versus conventional antenatal care for women. Homer CSE, Ryan C, Leap N, Foureur M, Teate A, Catling-Paull CJ, Cochrane Database Syst Rev 2012 11 11 D007622 23152247
36. Maternal hematologic levels and pregnancy outcomes. Garn SM, Ridella SA, Petzold AS, Falkner F, Semin Perinatol 1981 5 155 7198826
37. Cellular immunity status in anaemia in pregnancy. Kandoi A, Bhatia BD, Pandey LK, Pandey S, Sen PC, Satya K, Indian J Med Res 1991 94 11 2071177
38. Immune status of anaemic pregnant women. Prema K, Ramalakshmi BA, Madhavapeddi R, Babu S, BJOG 1982 89 3 222 225 10.1111/j.1471-0528.1982.tb03619.x
39. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Scholl TO, Hediger ML, Fischer RL, Shearer JW, Am J Clin Nutr 1992 55 5 985 988 1570808
40. Guidelines for the eradication of iron deficiency anemia: a report. International Nutritional Anemia Consultative G, Nutrition Foundation 1977
41. Daily oral iron supplementation during pregnancy. Pena-Rosas J, De-Regil L, Dowswell T, Viteri F, Cochrane Database Syst Rev 2012 12 12 D004736 23235616
42. Effect of routine iron supplementation with or without folic acid on anemia during pregnancy. Yakoob M, Bhutta Z, BMC Public Health 2011 11 3 21 21501439
43. Folic acid supplementation during pregnancy formaternal health and pregnancyoutcomes. Lassi Z, Salam R, Haider B, Bhutta Z, Cochrane Database Syst Rev 2013 3 3 D006896 23543547
44. Vaccines for women to prevent neonatal tetanus. Demicheli V, Barale A, Rivetti A, Cochrane Database Syst Rev 2005 4 12 D002959 16235306
45. Tetanus: Study of 8697 cases∗. Patel JC, Mehta BC, Indian J Med Sci 1999 53 9 393 10710833
46. Expanded programme on immunization: Prevention of neonatal tetanus. WHO, Weekly Epidemiological Record WHO 1982 57
47. Vaccines for women to prevent neonatal tetanus. Demicheli V, Barale A, Rivetti A, Cochrane Database Syst Rev 2013 5 5 D002959 23728640
48. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S, Int J Epidemiol 2010 39 suppl 1 102 i109 20348112
49. The contribution of malaria in pregnancy to perinatal mortality. van Geertruyden J-P, Thomas F, Erhart A, D Alessandro U, Am J Trop Med Hyg 2004 71 2 suppl 35 40 15331817
50. The African summit on Roll Back Malaria. World Health Organization, Abuja, Nigeria 2000 http://savekids.dzopus.org/pdfs/African%20Summit%20on%20Roll%20Back%20Malaria.pdf
51. Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in AfricaSystematic Review and Meta-analysisMalaria Prophylaxis and Risk of Low Birth Weight. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, JAMA 2013 309 6 594 604 10.1001/jama.2012.216231 23403684
52. Drugs for preventing malaria in pregnant women. Garner P, Gulmezoglu AM, Cochrane Database Syst Rev 2006 4 4 D000169 17054128
53. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy. Ter Kuile FO, van Eijk AM, Filler SJ, JAMA 2007 297 23 2603 2616 10.1001/jama.297.23.2603 17579229
54. Insecticide-treated bed nets and curtains for preventing malaria. Lengeler C, Cochrane Database Syst Rev 2004 2 2 D000363 15106149
55. Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials. Gamble C, Ekwaru PJ, Garner P, ter Kuile FO, PLoS Med 2007 4 3 107 10.1371/journal.pmed.0040107 17388668
56. Insecticide-treated nets for preventing malaria in pregnancy. Gamble C, Ekwaru JP, ter Kuile FO, Cochrane Database Syst Rev 2006 2 2 D003755 16625591
57. Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas. Eisele TP, Larsen D, Steketee RW, Int J Epidemiol 2010 39 suppl 1 88 i101 20348132
58. Interventions for promoting smoking cessation during pregnancy. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L, Cochrane Database Syst Rev 2009 3 3 D001055 19588322
59. Pharmacological interventions for promoting smoking cessation during pregnancy. Coleman T, Chamberlain C, Davey M-A, Cooper SE, Leonardi-Bee J, Cochrane Database Syst Rev 2012 9 9 D010078 22972148
60. Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Who U, Unicef, Progress report November 2011
61. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. Blencowe H, Cousens S, Kamb M, Berman S, Lawn JE, BMC Public Health 2011 11 Suppl 3 9 10.1186/1471-2458-11-S3-S9
62. Antibiotics for syphilis diagnosed during pregnancy. Walker GJ, Cochrane Database Syst Rev 2001 4 4 D001143
63. Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention (CDC), Morbidity and Mortality Weekly Report 2002 51 RR-6 1 80
64. Triple-antiretroviral (ARV) prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1 (MTCT): the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya. De Vincenzi I, 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, 19-22 July 2009: 2009 2009
65. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection. Wiysonge CS, Shey M, Kongnyuy EJ, Sterne JA, Brocklehurst P, Cochrane Database Syst Rev 2011 1 1 D003648 21249656
66. Vaginal disinfection during labour for reducing the risk of motherâ toâ child transmission of HIV infection. Shey WCU, Brocklehurst P, Sterne JAC, Cochrane Database Syst Rev 2002 3 3 D003651 12137703
67. Triple-antiretroviral prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1: the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa. Kesho Bora Study G, Fifth International AIDS Society Conference on HIV Treatment, Pathogenesis and Prevention: 2009 2009
68. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Read J, Newell M, Cochrane Database Syst Rev 2005 4 4 D005479 16235405
69. Report on Maternal Deaths in Australia 1988-1990. Canberra, Australia: Government Publising Service. NHMRC, 1993
70. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1988-1990. London: HMSO: Department of Health Welsh Office, Scottish Office Home and Health Department, Department of Health and Social Security, Northern Ireland. HMSO, 1994
71. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, Merialdi M, Int J Gynaecol Obstet 2004 85 28 S41 15147852
72. The relationship between calcium intake and edema, proteinuria and hypertension gestosis. A hypothesis. Belizán JM, Villar J, American Journal of Clinical Nutrition 1980 33 2202 2210 6999886
73. Calcium supplementation to prevent hypertensive disorders of pregnancy. Belizán JM, Villar J, Bergel E, González L, Campodónico L, New England Journal of Medicine 1991 325 1399 1405 10.1056/NEJM199111143252002 1922250
74. Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. Belizán JM, Villar J, Zalazar A, Rojas L, Chan D, Bryce GF, American Journal of Obstetrics and Gynecology 1983 146 175 180 6846435
75. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Cochrane Database of Systematic Reviews 2013 Issue 11
76. The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. Belizán JM, Villar J, Repke J, Am J Obstet Gynecol 1988 158 4 898 10.1016/0002-9378(88)90091-9 3284363
77. The mediating role of the parathyroid gland in the effect of low calcium intake on blood pressure in the rat. Belizán JM, Villar J, Self S, Pineda O, González I, Sainz E, Archivos Latinoamericanos de Nutrición 1984 34 666 675
78. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. Imdad A, Jabeen A, Bhutta ZA, BMC Public Health 2011 11 Suppl 3 18 10.1186/1471-2458-11-S3-S18 21501435
79. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Hofmeyr GJ, Lawrie TA, Atallah lN, Duley L, Cochrane Database Syst Rev 2010 8 8 D001059 20687064
80. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. Hofmeyr GJ, Duley L, Atallah A, BJOG 2007 114 8 933 943 10.1111/j.1471-0528.2007.01389.x 17565614
81. Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. Jabeen M, Yakoob MY, Imdad A, Bhutta ZA, BMC Public Health 2011 11 Suppl 3 6 10.1186/1471-2458-11-S3-S6
82. Maternal vascular prostacyclin activity in pre-eclampsia. Bussolino F, Benedetto C, Massobrio M, Camussi G, Lancet 1980 316 8196 702 10.1016/S0140-6736(80)92746-4
83. Antiplatelet agents for preventing pre-eclampsia and its complications. Duley L, Henderson-Smart DJ, Meher S, King JF, Cochrane Database Syst Rev 2007 4 4 D004659
84. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, Lancet 2007 369 9575 1791 1798 10.1016/S0140-6736(07)60712-0 17512048
85. Department of Health, Welsh Office, Scottish Home and Health Department, Department of Health and Social Security, Northern Ireland. Report on Confidential Inquiries into Maternal Deaths in the United Kingdom 1994-96. London: HMSO. DH, 1998
86. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Duley L, BJOG 1992 99 7 547 553 10.1111/j.1471-0528.1992.tb13818.x
87. The classification and definition of the hypertensive disorders of pregnancy. Davey DA, MacGillivray I, Am J Obstet Gynecol 1988 158 4 892 898 10.1016/0002-9378(88)90090-7 3364501
88. Drugs for treatment of very high blood pressure during pregnancy. Duley L, Meher S, Jones L, Cochrane Database Syst Rev 2013 7 7 D001449 23900968
89. Oral beta-blockers for mild to moderate hypertension during pregnancy. Magee LA, Duley L, Cochrane Database Syst Rev 2003 3 3 D002863 12917933
90. Magnesium sulphate versus diazepam for eclampsia. Duley L, Henderson-Smart DJ, Walker GJ, Chou D, Cochrane Database Syst Rev 2010 12 12 D000127 21154341
91. Magnesium sulphate versus phenytoin for eclampsia. Duley L, Henderson-Smart DJ, Chou D, Cochrane Database Syst Rev 2010 10 10 D000128 20927719
92. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D, Cochrane Database Syst Rev 2010 11 11 D000025 21069663
93. Magnesium sulphate versus lytic cocktail for eclampsia. Duley L, Gulmezoglu AM, Chou D, Cochrane Database Syst Rev 2010 9 9 D002960 20824833
94. Predictors of successful external cephalic version at term: a prospective study. Lau TK, Lo KWK, Wan D, Rogers MS, BJOG 1997 104 7 798 802 10.1111/j.1471-0528.1997.tb12023.x
95. Interventions for helping to turn term breech babies to head first presentation when using external cephalic version. Cluver C, Hofmeyr GJ, Gyte GM, Sinclair M, Cochrane Database Syst Rev 2012 1 1 D000184 22258940
96. External cephalic version for breech presentation before term. Hutton EK, Hofmeyr GJ, Cochrane Database Syst Rev 2006 1 1 D000084 16437421
97. Cephalic version by postural management for breech presentation. Hofmeyr G, Kulier R, Cochrane Database Syst Rev 2012 10 10 D000051 23076882
98. External cephalic version for breech presentation at term. Hofmeyr GJ, Kulier R, Cochrane Database Syst Rev 2012 10 10 D000083 23076883
99. Planned caesarean section for term breech delivery. Hofmeyr GJ, Hannah ME, Lawrie TA, Cochrane Database Syst Rev 2003 2 2 D000166
100. Cephalic version by moxibustion for breech presentation. Coyle ME, Smith CA, Peat B, Cochrane Database Syst Rev 2012 5 5 D003928 22592693
101. Premature rupture of the membranes at term. Duff P, N Engl J Med 1996 334 16 1053 1054 10.1056/NEJM199604183341609 8598845
102. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Buchanan SL, Crowther CA, Levett KM, Middleton P, Morris J, Cochrane Database Syst Rev 2010 3 3 D004735 20238332
103. Antibiotics for preterm rupture of membranes. Kenyon S, Boulvain M, Neilson JP, Cochrane Database Syst Rev 2010 8 8 D001058 20687063
104. Antibiotics for pre-term pre-labour rupture of membranes: prevention of neonatal deaths due to complications of pre-term birth and infection. Cousens S, Blencowe H, Gravett M, Lawn JE, Int J Epidemiol 2010 39 suppl 1 134 i143 20348116
105. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Roberts D, Dalziel S, Cochrane Database Syst Rev 2006 3 3 D004454 16856047
106. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Crowley P, Chalmers I, Ke1Rse MJ, BJOG 1990 97 1 11 25 10.1111/j.1471-0528.1990.tb01711.x
107. FETAL LUNG MATURITY. Purandare C, J Obstet Gynecol India 2005 55 3 215 217
108. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn JE, Int J Epidemiol 2010 39 suppl 1 122 i133 20348115
109. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Brownfoot FC, Crowther CA, Middleton P, Cochrane Database Syst Rev 2008 4 4 D006764 18843729
110. The prevention and management of unsafe abortion.Report of a Technical Working Group. World Health Organization, 1992 http://whqlibdoc.who.int/hq/1992/WHO-MSM-92.5.pdf
111. Commentary: the public health consequences of restricted induced abortion - lessons from Romania. Stephenson P, Wagner M, Badea M, Serbanescu F, Am J Public Health 1992 82 10 1328 1331 10.2105/AJPH.82.10.1328 1415854
112. Scaling up post-abortion care in Guatemala: initial successes at national level. Kestler E, Valencia L, Del Valle V, Silva A, Reprod Health Matters 2006 14 27 138 147 10.1016/S0968-8080(06)27235-5 16713888
113. Safe abortion: technical and policy guidance for health systems. World Health Organization, World Health Organization 2003
114. Alma-Ata: Rebirth and Revision 6 Interventions to address maternal, newborn, and child survival: what difference can integrated primary health care strategies make? Bhutta ZA, Ali S, Cousens S, Ali TM, Haider BA, Rizvi A, Okong P, Bhutta SZ, Black RE, Lancet 2008 372 9642 972 989 10.1016/S0140-6736(08)61407-5 18790320
115. Delivering interventions to reduce the global burden of stillbirths: improving service supply and community demand. Bhutta ZA, Darmstadt GL, Haws RA, Yakoob MY, Lawn JE, BMC Pregnancy and Childbirth 2009 9 Supplement 1 7 19426470
116. Systematic review of effect of community-level interventions to reduce maternal mortality. Kidney E, Winter HR, Khan KS, Gumezoglu AM, Meads CA, Deeks JJ, MacArthur C, BMC Pregnancy and Childbirth 2009 9 1 2 10.1186/1471-2393-9-2 19154588
117. Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes. Lassi ZS, Haider BA, Bhutta ZA, Cochrane Database Syst Rev 2010 11 11 D007754 21069697
118. Home visits by community health workers to prevent neonatal deaths in developing countries: a systematic review. Gogia S, Sachdev HS, Bull World Health Organ 2010 88 9 658 666 10.2471/BLT.09.069369 20865070
119. Strategies for reducing maternal mortality: getting on with what works. Campbell OM, Graham WJ, Lancet 2006 368 9543 1284 1299 10.1016/S0140-6736(06)69381-1 17027735
120. Community-based interventions for improving perinatal and neonatal health outcomes in developing countries: a review of the evidence. Bhutta ZA, Darmstadt GL, Hasan BS, Haws RA, Pediatrics 2005 115 Supplement 2 519 617 15866863